Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors
Diedrich, D., Hamacher, A., Gertzen, C. G. W., Avelar, L. A. Alves, Reiss, G. J., Kurz, T., Gohlke, H., Kassack, M. U., Hansen, F. K.
Published in Chemical communications (Cambridge, England) (01.01.2016)
Published in Chemical communications (Cambridge, England) (01.01.2016)
Get full text
Journal Article
Stability of murine bradykinin type 2 receptor despite treatment with NO, bradykinin, icatibant, or C1‐INH
Khosravani, F., Suvorava, T., Dao, V. T.‐V., Brockmann, N., Kocgirli, O., Herbst, F. F., Valcaccia, S., Kassack, M. U., Bas, M., Kojda, G.
Published in Allergy (Copenhagen) (01.03.2015)
Published in Allergy (Copenhagen) (01.03.2015)
Get full text
Journal Article
In vitro and mouse in vivo characterization of the potent free fatty acid 1 receptor agonist TUG-469
Urban, C., Hamacher, A., Partke, H. J., Roden, M., Schinner, S., Christiansen, E., Due-Hansen, M. E., Ulven, T., Gohlke, H., Kassack, M. U.
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.12.2013)
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.12.2013)
Get full text
Journal Article
Structure-Activity Relationships of Suramin and Pyridoxal-5-phosphate Derivatives as P2 Receptor Antagonists
Lambrecht, Günter, Braun, Kirsten, Damer, MiSusannechelle, Ganso, Matthias, Hildebrandt, Caren, Ullmann, Heiko, Kassack, Matthias U, Nickel, Peter
Published in Current pharmaceutical design (01.12.2002)
Published in Current pharmaceutical design (01.12.2002)
Get full text
Journal Article
Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X receptor antagonist
RETTINGER, J, BRAUN, K, HOCHMANN, H, KASSACK, M, ULLMANN, H, NICKEL, P, SCHMALZING, G, LAMBRECHT, G
Published in Neuropharmacology (01.03.2005)
Published in Neuropharmacology (01.03.2005)
Get full text
Journal Article
Suramin Derivatives as Inhibitors and Activators of Protein-tyrosine Phosphatases
McCain, Daniel F., Wu, Li, Nickel, Peter, Kassack, Matthias U., Kreimeyer, Annett, Gagliardi, Antonio, Collins, Delwood C., Zhang, Zhong-Yin
Published in The Journal of biological chemistry (09.04.2004)
Published in The Journal of biological chemistry (09.04.2004)
Get full text
Journal Article
Differential gene expression studies in cisplatin-sensitive versus cisplatin-resistant human cancer cell lines
Gosepath, E M, Weykam, S, Gruenewald, E, Ko, Y, Wiese, M, Kassack, M U
Published in International journal of clinical pharmacology and therapeutics (01.11.2004)
Published in International journal of clinical pharmacology and therapeutics (01.11.2004)
Get more information
Journal Article
Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitorsElectronic supplementary information (ESI) available: Experimental details (synthetic protocols, bioassays, X-ray crystallography, computational methods), characterization data of new compounds, and copies of NMR spectra. CCDC 1434499. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5cc10301k
Diedrich, D, Hamacher, A, Gertzen, C. G. W, Alves Avelar, L. A, Reiss, G. J, Kurz, T, Gohlke, H, Kassack, M. U, Hansen, F. K
Year of Publication 11.02.2016
Year of Publication 11.02.2016
Get full text
Journal Article
Stability of murine bradykinin type 2 receptor despite treatment with NO , bradykinin, icatibant, or C 1‐ INH
Khosravani, F., Suvorava, T., Dao, V. T.‐V., Brockmann, N., Kocgirli, O., Herbst, F. F., Valcaccia, S., Kassack, M. U., Bas, M., Kojda, G.
Published in Allergy (Copenhagen) (01.03.2015)
Published in Allergy (Copenhagen) (01.03.2015)
Get full text
Journal Article
Synthesis and structure-activity relationships of suramin-derived P2Y(11) receptor antagonists with nanomolar potency
Ullmann, H, Meis, S, Hongwiset, D, Marzian, C, Wiese, M, Nickel, P, Communi, D, Boeynaems, JM, Wolf, C, Hausmann, R, Schmalzing, G, Kassack, MU
Published in Journal of medicinal chemistry (03.11.2005)
Published in Journal of medicinal chemistry (03.11.2005)
Get full text
Journal Article
Molecular determinants of potent P2X2 antagonism identified by functional analysis, mutagenesis, and homology docking
Wolf, Christian, Rosefort, Christiane, Fallah, Ghada, Kassack, Matthias U, Hamacher, Alexandra, Bodnar, Mandy, Wang, Haihong, Illes, Peter, Kless, Achim, Bahrenberg, Gregor, Schmalzing, Günther, Hausmann, Ralf
Published in Molecular pharmacology (01.04.2011)
Published in Molecular pharmacology (01.04.2011)
Get full text
Journal Article
Salt bridge switching from Arg290/Glu167 to Arg290/ATP promotes the closed-to-open transition of the P2X2 receptor
Hausmann, Ralf, Günther, Janka, Kless, Achim, Kuhlmann, Daniel, Kassack, Matthias U, Bahrenberg, Gregor, Markwardt, Fritz, Schmalzing, Günther
Published in Molecular pharmacology (01.01.2013)
Published in Molecular pharmacology (01.01.2013)
Get full text
Journal Article
Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X(1) receptor antagonist
Kassack, MU, Braun, K, Ganso, M, Ullmann, H, Nickel, P, Boing, B, Muller, G, Lambrecht, G
Published in European journal of medicinal chemistry (01.04.2004)
Published in European journal of medicinal chemistry (01.04.2004)
Get full text
Journal Article
Dopamine/serotonin receptor ligands. 10: SAR studies on azecine-type dopamine receptor Ligands by functional screening at human cloned D-1, D-2L, and D-5 receptors with a microplate reader based calcium assay lead to a novel potent D-1/D-5 selective antagonist
Hoefgen, B, Decker, M, Mohr, P, Schramm, AM, Rostom, SAF, El-Subbagh, H, Schweikert, PM, Rudolf, DR, Kassack, MU, Lehmann, J
Published in Journal of medicinal chemistry (26.01.2006)
Published in Journal of medicinal chemistry (26.01.2006)
Get full text
Journal Article